Authors
Dr. Hari Shankar MBBS MD (Biochemistry)1, Dr. Krishnachandran R Msc PhD2, Dr. Sinto MS MSc PhD2.
1Department of Biochemistry & Immunology, DDRC Agilus Pathlabs Ltd, Kerala;
2Department of Molecular Genetics & Cytogenetics, DDRC Agilus Pathlabs Ltd, Kerala.
Abstract
NGS represents a ground-breaking technology facilitating swift, high-throughput sequencing of DNA or RNA molecules. NGS techniques empower the simultaneous parallel sequencing of millions to billions of DNA or RNA fragments, a capability unmatched by traditional Sanger sequencing, which is constrained by scalability and speed. The versatility of NGS platforms has expanded the scope of genomics research, enabling investigations into rare genetic diseases, cancer genomics, microbiome analysis, infectious diseases, and population genetics. Furthermore, NGS has paved the way for the advancement of targeted therapies, precision medicine strategies, and enhanced diagnostic methods.